Patents by Inventor Ralph M. Riggin

Ralph M. Riggin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040038288
    Abstract: An isolated human protein C polypeptide with a truncated heavy chain is described. This isolated polypeptide retains the biological activity of the wild-type human protein C. This polypeptide will be useful in the treatment of vascular occlusive disorders, hypercoagulable states, thrombotic disorders and disease states predisposing to thrombosis.
    Type: Application
    Filed: September 25, 2003
    Publication date: February 26, 2004
    Inventors: Lihua Huang, Ralph M. Riggin
  • Patent number: 5340541
    Abstract: Automation of the coulometric Karl Fischer titration has allowed for the accurate, precise determination of moisture content of lyophilized hGH formulations. The system of the present invention utilizes a vented, two-hole sampling/dispensing probe that dispenses titrant and withdraws sample solution through the closed container rubber septum into the Karl Fischer titration reaction vessel. This approach eliminates erroneous results due to environmental moisture contamination or loss of material during the sample transfer process. The system of the present invention is also equipped with a fixed loop valving system, which facilitates the precise measurement of a defined amount of water as a standard. This allows for an accurate accessment of system suitability that was lacking with commercial water standards due to inaccurate moisture content presumably from moisture contamination of the standard under storage and/or at the time of manufacture.
    Type: Grant
    Filed: March 5, 1993
    Date of Patent: August 23, 1994
    Assignee: Eli Lilly and Company
    Inventors: David A. Jackson, Ralph M. Riggin, John K. Towns
  • Patent number: 5068317
    Abstract: A sulfoxide of human growth hormone has been produced and characterized. The sulfoxide derivative arises from a selective oxidation of Met.sup.14. The sulfoxide exhibits full biological activity.
    Type: Grant
    Filed: March 15, 1988
    Date of Patent: November 26, 1991
    Assignee: Eli Lilly and Company
    Inventors: Gerald W. Becker, Ralph M. Riggin